Muscle strain. M62.6
Conditions
Interventions
Intervention 1: Conventional treatment (Napoxen, 500 mg, q12h,for 7 days) + Placebo(1 tablet, q12h, for 7 days). Intervention 2: Methocarbamol, Intramuscular, 1 Ampule, 1000 milligram intramuscular in
Placebo
Treatment - Drugs
Conventional treatment (Napoxen, 500 mg, q12h,for 7 days) + Placebo(1 tablet, q12h, for 7 days)
Methocarbamol, Intramuscular, 1 Ampule, 1000 milligram intramuscular in two buttocks + Conventional treatment Naproxen (1 tablet, 500mg, q12h, for 7days)
Oral Methocarbamol 2 tablet (1000 Milligram, q4h) for 3 days, then 2 tablet (q8h) for 4th days + Conventional treatment Naproxen (1 tablet, 500mg, q12h, for 7days)
Sponsors
Yasuj University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion: Onset of pain (acute pain,<2week), No history of trauma Exclusion: Radiculopathy, Fracture, Infection, Ligament sprain, Malignancy, Diabetes Mellitus, Thyroid disease, Underlying disease, Rheumatic disease, Myopathy, Motor Neuron disease, Neuropathy
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: In start of treatment and 7-10 days later. Method of measurement: Visual analogue scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRuhallah Hossini
Yasuj medical College
Outcome results
None listed